Drug Research

Scope & Guideline

Transforming Ideas into Therapeutic Realities

Introduction

Explore the comprehensive scope of Drug Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Drug Research in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2194-9379
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Converge1972, from 2013 to 2024
AbbreviationDRUG RES / Drug Res.
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

The journal 'Drug Research' is dedicated to advancing the field of pharmacology and drug development through rigorous scientific inquiry. Its primary focus encompasses a wide range of topics, particularly emphasizing innovative methodologies and therapeutic strategies. As evidenced by the diverse titles of papers published in recent years, the journal aims to elucidate the complexities of drug interactions, therapeutic efficacy, and safety profiles, while also exploring novel drug formulations and delivery systems.
  1. Pharmacological Studies:
    Research on the pharmacodynamics and pharmacokinetics of various drugs, including their mechanisms of action and therapeutic effects across different conditions.
  2. Drug Development and Formulation:
    Exploration of novel drug formulations, including nanoparticles, liposomes, and other delivery systems to enhance drug efficacy and minimize side effects.
  3. Clinical and Preclinical Research:
    Investigation of drug efficacy and safety through clinical trials, observational studies, and preclinical animal models.
  4. Toxicology and Safety Assessment:
    Examination of drug-induced toxicity and adverse effects, focusing on mechanisms of toxicity and strategies for mitigating risks.
  5. Repurposing Existing Drugs:
    Research aimed at identifying new therapeutic uses for established medications, enhancing their utility in treating various conditions.
  6. Natural Products and Phytochemistry:
    Investigation of the pharmacological properties of natural compounds and their potential applications in drug development.
  7. Artificial Intelligence and Computational Drug Discovery:
    Utilization of AI and computational methods for drug discovery, including molecular docking and virtual screening techniques.
The journal 'Drug Research' has witnessed a notable evolution in its thematic focus, with certain areas gaining prominence in recent publications. These emerging themes reflect current scientific interests and the pressing needs of the medical community, particularly in response to global health challenges. The following trends highlight the journal's adaptive nature and commitment to addressing contemporary issues in drug research.
  1. Artificial Intelligence in Drug Discovery:
    A growing trend is the application of AI and machine learning techniques in drug discovery and development, enabling more efficient identification of potential drug candidates and predictive modeling of drug interactions.
  2. Investigations into COVID-19 Treatments:
    Research focused on therapeutic strategies for COVID-19 has surged, with numerous studies evaluating existing drugs and novel compounds for their efficacy against the virus.
  3. Nanomedicine and Targeted Delivery Systems:
    There is an increasing emphasis on nanotechnology in drug delivery, exploring how nanoparticles can enhance the bioavailability and targeted delivery of therapeutic agents.
  4. Drug Repurposing Strategies:
    Repurposing existing drugs for new therapeutic indications has gained traction, particularly in the context of urgent health crises, allowing rapid deployment of effective treatments.
  5. Neuropharmacology and Neurodegenerative Disorders:
    Research on pharmacological interventions for neurodegenerative diseases, including Alzheimer's and Parkinson's disease, is on the rise, reflecting the pressing need for effective therapies in this area.

Declining or Waning

Over the years, certain research themes within 'Drug Research' have seen a decline in publication frequency. This waning interest may reflect shifts in research priorities, funding availability, or advancements in other areas that have captured the attention of the scientific community. The following themes appear to be less prominent in recent issues of the journal.
  1. Gastrointestinal Drug Development:
    While there has been significant interest in gastrointestinal diseases, the specific focus on drug therapy for these conditions has diminished, possibly due to emerging therapies targeting other systems or diseases.
  2. Traditional Herbal Medicine:
    Although historically significant, the exploration of traditional herbal medicines as standalone treatments has decreased, likely as a result of a growing emphasis on scientifically validated pharmaceuticals.
  3. Viral Hepatitis Research:
    Research specifically focused on viral hepatitis has seen a reduction in publications, potentially overshadowed by the urgency of research related to COVID-19 and other emerging infectious diseases.
  4. Conventional Drug Delivery Systems:
    Interest in conventional drug delivery methods has waned in favor of more innovative and advanced delivery systems, such as nanotechnology-based approaches.
  5. Basic Pharmacology of Established Drugs:
    The basic pharmacological studies of well-established drugs are less frequently published, as researchers are increasingly focused on novel compounds and mechanisms.

Similar Journals

BMC Pharmacology & Toxicology

Your gateway to groundbreaking pharmacological insights.
Publisher: BMCISSN: Frequency: 1 issue/year

Welcome to BMC Pharmacology & Toxicology, a premier open-access journal dedicated to advancing the fields of pharmacology and toxicology. Published by BMC since 2012, this esteemed journal offers a platform for researchers, professionals, and students to disseminate cutting-edge research and innovative findings that explore the intricate interactions between drugs and biological systems. With its robust Q2 ranking in both general medicine and pharmacology categories for 2023, BMC Pharmacology & Toxicology is recognized for its significant contributions to the academic community, reflected in its strategic positioning within the 61st and 49th percentiles in Scopus rankings for related disciplines. The journal's commitment to open access ensures that vital research is accessible to a global audience, fostering collaboration and informed discussions. We invite you to engage with the latest studies, reviews, and innovative methodologies that shape the future of pharmacological and toxicological sciences.

BRITISH JOURNAL OF PHARMACOLOGY

Elevating research standards in the field of pharmacology.
Publisher: WILEYISSN: 0007-1188Frequency: 24 issues/year

British Journal of Pharmacology is a premier, peer-reviewed journal published by Wiley, specializing in the dynamic field of pharmacology. With a robust impact factor, this journal ranks in the top quartile (Q1) for pharmacology according to the 2023 category rankings, emphasizing its significance and reputation among the global scientific community. As an essential resource for researchers, professionals, and students alike, the journal provides a platform for innovative research spanning foundational studies to clinical applications in pharmacology, toxicology, and pharmaceutics. Since its inception in 1966, the journal has consistently contributed to the advancement of pharmacological science, fostering a deeper understanding of drug action mechanisms and therapeutic advancements. Although primarily subscription-based, the British Journal of Pharmacology is committed to disseminating high-quality research that shapes the future of the field.

SCIENTIA PHARMACEUTICA

Elevating the discourse in pharmacology and pharmaceutics.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

Iranian Journal of Pharmaceutical Research

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Exploring Therapeutic Breakthroughs for Better Animal Welfare
Publisher: WILEYISSN: 0140-7783Frequency: 6 issues/year

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS is a crucial publication in the field of veterinary medicine, dedicated to advancing knowledge and practices related to pharmacology and therapeutic interventions in animals. Published by WILEY, this peer-reviewed journal has been a reliable source of innovative research since its inception in 1978, and it continues to play an integral role in shaping veterinary pharmacology through its commitment to high-quality scientific discourse. With an impact factor reflective of its robust academic standing, the journal is categorized in the Q3 quartile for Pharmacology and Q2 for Veterinary (miscellaneous) as of 2023, highlighting its relevance and significance within these domains. It is indexed in Scopus with commendable rankings, particularly in General Veterinary, where it ranks #45 out of 194, placing it in the 77th percentile. This journal not only offers a platform for original research articles but also caters to the dissemination of practical applications and reviews that are essential for veterinarians, researchers, and students alike in enhancing animal health and welfare. Although not an open-access publication, its contributions remain accessible to those engaged in the veterinary sciences through institutional subscriptions. The journal's enduring legacy and forward-looking approach make it a vital resource for anyone interested in veterinary therapeutics and pharmacology.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Delivering High-Impact Research for Healthcare Professionals
Publisher: WILEYISSN: 1742-7835Frequency: 12 issues/year

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

European Journal of Pharmacology

Exploring the frontiers of therapeutic applications and drug development.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

MEDICINAL RESEARCH REVIEWS

Advancing the Frontiers of Therapeutic Innovation
Publisher: WILEYISSN: 0198-6325Frequency: 6 issues/year

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

Journal of Pharmacological Sciences

Empowering health through cutting-edge pharmacological insights.
Publisher: JAPANESE PHARMACOLOGICAL SOCISSN: 1347-8613Frequency: 12 issues/year

Journal of Pharmacological Sciences is a leading peer-reviewed academic journal dedicated to the field of pharmacology, published by the Japanese Pharmacological Society. Since its inception, this journal has offered an essential platform for the dissemination of high-quality research, contributing significantly to advancements in molecular medicine and pharmacology. With an impact factor that places it in the prestigious Q2 quartile for both categories, the journal has established itself as a credible source of innovative findings and methodologies since its transition to Open Access in 2015. This accessibility enables a broader audience, including researchers, healthcare professionals, and students, to engage with valuable insights and discussions pertinent to drug development, pharmacodynamics, and therapeutic strategies. Based in Kyoto, Japan, the journal serves as a vital resource for the global pharmacological community, encouraging collaboration and research that leads to improved health outcomes. For more information, submissions, and access to the latest research, visit the journal’s website.

ACS Pharmacology & Translational Science

Driving breakthroughs from bench to bedside.
Publisher: AMER CHEMICAL SOCISSN: Frequency: 12 issues/year

ACS Pharmacology & Translational Science is a premier journal published by the American Chemical Society, dedicated to advancing knowledge in the fields of pharmacology and translational science. Operating since 2018, the journal has quickly established itself as a leader in its domain, holding a prestigious Q1 ranking in both Pharmacology and Medical Pharmacology for 2023. With a robust Scopus ranking, it currently occupies the 21st position out of 272 in Medical Pharmacology, reflecting its significant impact within the scientific community at the 92nd percentile. The journal provides an open-access platform for researchers to disseminate innovative findings and viewpoints that bridge the gap between drug discovery and clinical application. In an era where translational research is critical for the success of pharmacological advances, ACS Pharmacology & Translational Science serves as an essential resource for scientists, professionals, and students eager to explore cutting-edge developments in drug development and therapeutic strategies. The journal is based in the United States, with a commitment to fostering collaboration and knowledge sharing across borders.